NanoVibronix’s PainShield Included in V.A. Contract

NanoVibronix Inc.’s PainShield product is now included in the U.S. Department of Veteran Affairs’ (VA) Federal Supply Schedule (FSS), a program that supports the healthcare acquisition needs of the VA and other government agencies.
 
The VA awarded a five-year FSS contract to Delta Medical LLC, a service-disabled veteran-owned small business and distributor of NanoVibronix’s PainShield product. The FSS contract includes the PainShield device.
 
“As the largest integrated health care network in the U.S., the VA represents a massive opportunity for the placement of our PainShield devices,” NanoVibronix CEO Brian Murphy said. “The VA serves 9 million enrolled veterans each year and including our PainShield product in the FSS will help the VA meet its healthcare acquisition needs. Healthcare providers both within and outside of the VA are urgently seeking non-pharmacological treatment modalities for the management of pain, and PainShield is a proven therapeutic that directly addresses this growing need. We are energized by the possibilities for increased adoption with the award of this contract to Delta Medical.”
 
“As the sole set-aside and eligible SDVOSB that provides VA access to at-home, low-frequency ultrasound therapy, this contract will allow us to pursue sole source distribution agreements across the country. These sole source, set-aside, eligible agreements will allow us to better serve a larger veteran population while decreasing the financial and technical burden the VA experiences during the acquisition process for these types of medical devices,” Delta Medical Principal Owner Justin A. Brooks added. “We are excited for this new chapter in our partnership with NanoVibronix and the VA community as a whole.”
 
NanoVibronix Inc. is a medical device company headquartered in Elmsford, N.Y., with research and development in Nesher, Israel. The firm develops medical devices using its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety to medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without professional medical assistance.